세계의 인공눈물 시장 : 부문별 예측(2025-2030년)

The Artificial Tears Market was valued at USD 2.06 billion in 2023, expected to reach USD 2.23 billion in 2024, and is projected to grow at a CAGR of 8.27%, to USD 3.60 billion by 2030.

The artificial tears market focuses on products designed to lubricate and hydrate the eyes, primarily used to alleviate dryness and irritation. The necessity for artificial tears arises from various conditions such as dry eye syndrome, prolonged screen time, aging, and environmental factors. Applications of artificial tears are expanding beyond mere eye hydration to include post-surgery care and enhanced visual comfort for contact lens users. End users range from individual consumers to healthcare facilities, providing broad scope across retail and medical sectors. Key growth influencers include increasing digital device usage leading to eye strain, a growing aging population more susceptible to dry eye conditions, and innovations in product formulations, like preservative-free options and advanced delivery systems. Recent opportunities stem from the rise in awareness about eye health and increased demand for over-the-counter (OTC) products, emphasizing the need for brands to enhance presence in retail and e-commerce channels.

However, market growth faces challenges such as product recall incidents affecting consumer trust and stringent regulatory hurdles governing medical products. Competition from established pharmaceutical companies and brand loyalty also pose significant barriers. Innovation opportunities are ripe in areas like developing multifunctional artificial tears, eco-friendly packaging, and personalized eye care solutions using AI. Thus, companies should invest in R&D for novel formulations and leverage digital marketing to captivate tech-savvy consumers. Additionally, partnerships with healthcare providers can enhance distribution networks. Understanding regional variances in regulatory landscapes and consumer behaviors is vital for optimizing market penetration strategies. While the market is currently consumer-driven with a growth focus in North America and Asia-Pacific regions, strategic geographic expansions, coupled with investments in technology, can amplify future growth prospects. Businesses must align with sustainability trends and prioritize consumer education about eye health to fully capitalize on market opportunities while addressing inherent challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Tears Market

The Artificial Tears Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of eye disorders worldwide
  • Increasing prevalence of dry eye syndrome
  • Growing awareness and inclination towards early diagnosis and treatment
• Market Restraints
  • Short-term effects of artificial tears
• Market Opportunities
  • Introduction of improved artificial tears with enhanced stability
  • Significant investments in developing innovative artificial tear formulations
• Market Challenges
  • Risk pertaining to the use of contaminated artificial tears

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Tears Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Tears Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Tears Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Tears Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Tears Market

A detailed market share analysis in the Artificial Tears Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Tears Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Tears Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Tears Market

A strategic analysis of the Artificial Tears Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Tears Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Vision LLC, Bausch & Lomb Incorporated, Bayer AG, Horus Pharma, Johnson & Johnson Services, Inc., Nicox S.A., Novartis AG, Novax Pharma, Oasis Medical, Inc., OCuSOFT Inc., OmniVision GmbH, Otsuka Pharmaceutical Co., Ltd., Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co., Ltd., Scope Ophthalmics Ltd., Shire PLC by Takeda Pharmaceutical Company Limited, Similasan Corporation, Sun Pharmaceutical Industries, Inc., Taiwan Biotech Co., Ltd., Thea Pharmaceuticals Ltd., URSAPHARM Arzneimittel GmbH, Visufarma, and ZEISS Group.

Market Segmentation & Coverage

This research report categorizes the Artificial Tears Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Cellulose-derived, Glycerin-derived, Oil-based Emulsion, Polyethylene Glycol-based, Propylene Glycol-based, and Sodium Hyaluronate-based.
• Based on Application, market is studied across Contact Lens Moisture and Dry Eye Treatment.
• Based on Delivery Mode, market is studied across Eye Drops and Ointments.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of eye disorders worldwide
    • 5.1.1.2. Increasing prevalence of dry eye syndrome
    • 5.1.1.3. Growing awareness and inclination towards early diagnosis and treatment
  • 5.1.2. Restraints
    • 5.1.2.1. Short-term effects of artificial tears
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of improved artificial tears with enhanced stability
    • 5.1.3.2. Significant investments in developing innovative artificial tear formulations
  • 5.1.4. Challenges
    • 5.1.4.1. Risk pertaining to the use of contaminated artificial tears
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Tears Market, by Product Type

• 6.1. Introduction
• 6.2. Cellulose-derived
• 6.3. Glycerin-derived
• 6.4. Oil-based Emulsion
• 6.5. Polyethylene Glycol-based
• 6.6. Propylene Glycol-based
• 6.7. Sodium Hyaluronate-based

7. Artificial Tears Market, by Application

• 7.1. Introduction
• 7.2. Contact Lens Moisture
• 7.3. Dry Eye Treatment

8. Artificial Tears Market, by Delivery Mode

• 8.1. Introduction
• 8.2. Eye Drops
• 8.3. Ointments

9. Americas Artificial Tears Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Artificial Tears Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Tears Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Alcon Vision LLC
• 3. Bausch & Lomb Incorporated
• 4. Bayer AG
• 5. Horus Pharma
• 6. Johnson & Johnson Services, Inc.
• 7. Nicox S.A.
• 8. Novartis AG
• 9. Novax Pharma
• 10. Oasis Medical, Inc.
• 11. OCuSOFT Inc.
• 12. OmniVision GmbH
• 13. Otsuka Pharmaceutical Co., Ltd.
• 14. Prestige Consumer Healthcare Inc.
• 15. Santen Pharmaceutical Co., Ltd.
• 16. Scope Ophthalmics Ltd.
• 17. Shire PLC by Takeda Pharmaceutical Company Limited
• 18. Similasan Corporation
• 19. Sun Pharmaceutical Industries, Inc.
• 20. Taiwan Biotech Co., Ltd.
• 21. Thea Pharmaceuticals Ltd.
• 22. URSAPHARM Arzneimittel GmbH
• 23. Visufarma
• 24. ZEISS Group